Inna Kuperstein
Cited by
Cited by
Fibroblast heterogeneity and immunosuppressive environment in human breast cancer
A Costa, Y Kieffer, A Scholer-Dahirel, F Pelon, B Bourachot, M Cardon, ...
Cancer cell 33 (3), 463-479. e10, 2018
Creation and analysis of biochemical constraint-based models using the COBRA Toolbox v. 3.0
L Heirendt, S Arreckx, T Pfau, SN Mendoza, A Richelle, A Heinken, ...
Nature protocols 14 (3), 639-702, 2019
Neurotoxicity of Alzheimer's disease Aβ peptides is induced by small changes in the Aβ42 to Aβ40 ratio
I Kuperstein, K Broersen, I Benilova, J Rozenski, W Jonckheere, ...
The EMBO journal 29 (19), 3408-3420, 2010
Lipids revert inert Aβ amyloid fibrils to neurotoxic protofibrils that affect learning in mice
IC Martins, I Kuperstein, H Wilkinson, E Maes, M Vanbrabant, ...
The EMBO journal 27 (1), 224-233, 2008
The Virtual Metabolic Human database: integrating human and gut microbiome metabolism with nutrition and disease
A Noronha, J Modamio, Y Jarosz, E Guerard, N Sompairac, G Preciat, ...
Nucleic acids research 47 (D1), D614-D624, 2019
Atlas of Cancer Signalling Network: a systems biology resource for integrative analysis of cancer data with Google Maps
I Kuperstein, E Bonnet, HA Nguyen, D Cohen, E Viara, L Grieco, ...
Oncogenesis 4 (7), e160-e160, 2015
COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms
M Ostaszewski, A Mazein, ME Gillespie, I Kuperstein, A Niarakis, ...
Scientific data 7 (1), 136, 2020
Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut
M Chanrion, I Kuperstein, C Barrière, F El Marjou, D Cohen, D Vignjevic, ...
Nature communications 5 (1), 5005, 2014
Systems medicine disease maps: community-driven comprehensive representation of disease mechanisms
A Mazein, M Ostaszewski, I Kuperstein, S Watterson, N Le Novère, ...
NPJ systems biology and applications 4 (1), 21, 2018
Altered expression of key dopaminergic regulatory proteins in the postnatal brain following perinatal n‐3 fatty acid dietary deficiency
F Kuperstein, R Eilam, E Yavin
Journal of neurochemistry 106 (2), 662-671, 2008
COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms
M Ostaszewski, A Niarakis, A Mazein, I Kuperstein, R Phair, ...
Molecular systems biology 17 (10), e10387, 2021
ERK activation and nuclear translocation in amyloid‐β peptide‐and iron‐stressed neuronal cell cultures
F Kuperstein, E Yavin
European Journal of Neuroscience 16 (1), 44-54, 2002
NaviCell: a web-based environment for navigation, curation and maintenance of large molecular interaction maps
I Kuperstein, DPA Cohen, S Pook, E Viara, L Calzone, E Barillot, ...
BMC systems biology 7, 1-13, 2013
Overexpression of dopamine receptor genes and their products in the postnatal rat brain following maternal n‐3 fatty acid dietary deficiency
F Kuperstein, E Yakubov, P Dinerman, S Gil, R Eylam, N Salem Jr, ...
Journal of neurochemistry 95 (6), 1550-1562, 2005
Community-driven roadmap for integrated disease maps
M Ostaszewski, S Gebel, I Kuperstein, A Mazein, A Zinovyev, U Dogrusoz, ...
Briefings in bioinformatics 20 (2), 659-670, 2019
Pro‐apoptotic signaling in neuronal cells following iron and amyloid beta peptide neurotoxicity
F Kuperstein, E Yavin
Journal of neurochemistry 86 (1), 114-125, 2003
Differential role of specific PKC isoforms in the proliferation of glial cells and the expression of the astrocytic markers GFAP and glutamine synthetase
C Brodie, I Kuperstein, P Acs, PM Blumberg
Molecular brain research 56 (1-2), 108-117, 1998
A multiscale signalling network map of innate immune response in cancer reveals cell heterogeneity signatures
M Kondratova, U Czerwinska, N Sompairac, SD Amigorena, V Soumelis, ...
Nature communications 10 (1), 4808, 2019
The shortest path is not the one you know: application of biological network resources in precision oncology research
I Kuperstein, L Grieco, DPA Cohen, D Thieffry, A Zinovyev, E Barillot
Mutagenesis 30 (2), 191-204, 2015
Drug-driven synthetic lethality: bypassing tumor cell genetics with a combination of AsiDNA and PARP inhibitors
W Jdey, S Thierry, C Russo, F Devun, M Al Abo, P Noguiez-Hellin, JS Sun, ...
Clinical Cancer Research 23 (4), 1001-1011, 2017
The system can't perform the operation now. Try again later.
Articles 1–20